CareDx Inc. (1K9)
XDUS
Real-time Data
06:00 AM
Day's Range
39.4052 wk Range
9.80Overview - 1K9 - CareDx Inc.
Key Statistics
Valuation
Enterprise Value
-39.23M
P/E (Trailing)
‪-108.99‬
PEG Ratio
‪0.07‬
Price / Book
‪5.27‬
EV / EBITDA
‪-37.18‬
Profitability
Gross Margin
‪73.50%‬
Profit Margin
‪67.55%‬
Operating Margin
‪-6.60%‬
Return on Assets
‪-5.16%‬
Return on Equity
‪-7.04%‬
Ownership
Shares Outstanding
51.48M
Price stats
50-Day Avg
‪30.86‬
200-Day Avg
‪20.12‬
Peers - 1K9 - CareDx Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 1K9XDUSCareDx Inc.+74.05%52-week change-101.50P/E (Trailing)‪67.55%‬Profit Margin
- NL0XDUSGrail, Inc.+57.14%52-week change-5.92P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.56%52-week change-93.46P/E (Trailing)‪50.72%‬Profit Margin
- 04XXDUSPersonalis Inc.+66.42%52-week change-13.21P/E (Trailing)‪22.65%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.09%52-week change-41.53P/E (Trailing)‪64.46%‬Profit Margin
- NG9XDUSNeoGenomics Inc.+61.51%52-week change-16.39P/E (Trailing)‪43.21%‬Profit Margin
- NG2XDUSNeogen Corporation+51.76%52-week change-245.65P/E (Trailing)‪46.93%‬Profit Margin
Profile Summary - 1K9 - CareDx Inc.
About
CareDx Inc. is a leading precision medicine company that discovers, develops, and commercializes clinically differentiated diagnostic solutions for transplant patients and caregivers. It specializes in genomics-based testing services, including AlloSure Kidney and AlloSure Heart for donor-derived cell-free DNA…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
